TRIM13, tripartite motif containing 13, 10206

N. diseases: 275; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4725024
Disease: Refractory Leukemia
Refractory Leukemia
0.020 Biomarker disease BEFREE Chimeric antigen receptor T (CAR-T) cell therapies have been approved for use in relapsed or refractory leukemia and lymphoma based on promising efficacy in clinical trials. 30500439 2019
CUI: C4725024
Disease: Refractory Leukemia
Refractory Leukemia
0.020 GeneticVariation disease BEFREE The advent of chimeric antigen receptor T (CAR-T) and the burgeoning field of cellular therapy has revolutionized the treatment of relapsed/refractory leukemia and lymphoma. 31355491 2019